These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 12820312

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Pyruvate kinase M2 (tumor M2-PK) as a screening tool for colorectal cancer (CRC). A review of current published data].
    Ewald N, Toepler M, Akinci A, Kloer HU, Bretzel RG, Hardt PD.
    Z Gastroenterol; 2005 Dec; 43(12):1313-7. PubMed ID: 16315127
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tumor M2-pyruvate kinase: a promising tumor marker in the diagnosis of gastro-intestinal cancer.
    Hardt PD, Ngoumou BK, Rupp J, Schnell-Kretschmer H, Kloer HU.
    Anticancer Res; 2000 Dec; 20(6D):4965-8. PubMed ID: 11326648
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of faecal M2-PK and FIT in a population-based bowel cancer screening cohort.
    Leen R, Seng-Lee C, Holleran G, O'Morain C, McNamara D.
    Eur J Gastroenterol Hepatol; 2014 May; 26(5):514-8. PubMed ID: 24699725
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the Performance of a Fecal Tumor M2-PK Rapid Kit Using Stool Specimens for Detection of Colorectal Tumors.
    Cho CH, Kim J, Jang MA, Lee BJ, Park JJ, Lim CS.
    Ann Clin Lab Sci; 2016 May; 46(2):154-60. PubMed ID: 27098621
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fecal Adnab-9 binding as a risk marker for colorectal neoplasia.
    Yuan M, Xhang X, Leu Y, Xu Y, Ullah N, Lawson M, Tobi M.
    Cancer Lett; 2006 Apr 08; 235(1):48-52. PubMed ID: 15893419
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fecal lysozyme: an unreliable marker for colorectal cancer.
    Dubrow R, Kim CS, Eldred AK.
    Am J Gastroenterol; 1992 May 08; 87(5):617-21. PubMed ID: 1595650
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tumor type M2 pyruvate kinase expression in advanced breast cancer.
    Lüftner D, Mesterharm J, Akrivakis C, Geppert R, Petrides PE, Wernecke KD, Possinger K.
    Anticancer Res; 2000 May 08; 20(6D):5077-82. PubMed ID: 11326672
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.